1. Home
  2. CDLX vs BWAY Comparison

CDLX vs BWAY Comparison

Compare CDLX & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$0.62

Market Cap

53.5M

Sector

Technology

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$14.99

Market Cap

674.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDLX
BWAY
Founded
2008
2003
Country
United States
Israel
Employees
N/A
129
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
674.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CDLX
BWAY
Price
$0.62
$14.99
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$2.25
$13.25
AVG Volume (30 Days)
868.7K
133.6K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
50.13
N/A
EPS
N/A
N/A
Revenue
$233,273,000.00
N/A
Revenue This Year
N/A
$309.69
Revenue Next Year
$8.82
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$10.01
52 Week High
$3.28
$26.63

Technical Indicators

Market Signals
Indicator
CDLX
BWAY
Relative Strength Index (RSI) 27.89 40.25
Support Level $0.57 $14.56
Resistance Level $1.23 $16.63
Average True Range (ATR) 0.07 0.64
MACD -0.02 -0.19
Stochastic Oscillator 13.69 2.61

Price Performance

Historical Comparison
CDLX
BWAY

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: